<?xml version="1.0" encoding="UTF-8"?>
<p>Invasive fungal disease continues to have high morbidity and mortality and the development of adequate diagnostics has been challenging [
 <xref rid="B3-jof-07-00014" ref-type="bibr">3</xref>,
 <xref rid="B125-jof-07-00014" ref-type="bibr">125</xref>]. Fungal antigen tests, including BDG, represent advances toward the goal of improving the effective diagnosis of IFD. In order for them to be used effectively, it is critical that laboratories and health care practitioners are well acquainted with the factors that can influence results, within the patientâ€™s clinical context.
</p>
